EA201001368A1 - Гетероциклические производные мочевины и способы их применения-211 - Google Patents

Гетероциклические производные мочевины и способы их применения-211

Info

Publication number
EA201001368A1
EA201001368A1 EA201001368A EA201001368A EA201001368A1 EA 201001368 A1 EA201001368 A1 EA 201001368A1 EA 201001368 A EA201001368 A EA 201001368A EA 201001368 A EA201001368 A EA 201001368A EA 201001368 A1 EA201001368 A1 EA 201001368A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
application
urea derivatives
heterocyclic urea
heterocyclic
Prior art date
Application number
EA201001368A
Other languages
English (en)
Inventor
Шанта Бист
Брайан Данджел
Брайан Шерер
Original Assignee
Астразенека Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40474753&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201001368(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Астразенека Аб filed Critical Астразенека Аб
Publication of EA201001368A1 publication Critical patent/EA201001368A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

Описываются соединения формулы (I) и их фармацевтически приемлемые соли. Также описываются способы их получения, содержащие их фармацевтические композиции, их применение в качестве лекарственных средств и их применение при лечении бактериальных инфекций.
EA201001368A 2008-02-26 2009-02-25 Гетероциклические производные мочевины и способы их применения-211 EA201001368A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3162108P 2008-02-26 2008-02-26
PCT/GB2009/050187 WO2009106885A1 (en) 2008-02-26 2009-02-25 Heterocyclic urea derivatives and methods of use thereof-211

Publications (1)

Publication Number Publication Date
EA201001368A1 true EA201001368A1 (ru) 2011-04-29

Family

ID=40474753

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001368A EA201001368A1 (ru) 2008-02-26 2009-02-25 Гетероциклические производные мочевины и способы их применения-211

Country Status (23)

Country Link
US (1) US20120101100A1 (ru)
EP (1) EP2262801A1 (ru)
JP (1) JP2011513216A (ru)
KR (1) KR20100117681A (ru)
CN (1) CN102015699A (ru)
AR (1) AR070493A1 (ru)
AU (1) AU2009219883A1 (ru)
BR (1) BRPI0907562A2 (ru)
CA (1) CA2716365A1 (ru)
CL (1) CL2009000426A1 (ru)
CO (1) CO6290656A2 (ru)
CR (1) CR11641A (ru)
DO (1) DOP2010000259A (ru)
EA (1) EA201001368A1 (ru)
EC (1) ECSP10010419A (ru)
IL (1) IL207731A0 (ru)
MX (1) MX2010009163A (ru)
PE (1) PE20091573A1 (ru)
SA (1) SA109300138B1 (ru)
TW (1) TW200940537A (ru)
UY (1) UY31673A1 (ru)
WO (1) WO2009106885A1 (ru)
ZA (1) ZA201005997B (ru)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2250160B1 (en) 2008-01-25 2015-11-11 Millennium Pharmaceuticals, Inc. Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
AU2012203026B2 (en) * 2008-03-21 2014-06-12 Novartis Ag Novel heterocyclic compounds and uses thereof
US8865732B2 (en) 2008-03-21 2014-10-21 Novartis Ag Heterocyclic compounds and uses thereof
KR20110014710A (ko) * 2008-06-04 2011-02-11 아스트라제네카 아베 박테리아 감염의 치료를 위한 헤테로시클릭 우레아 유도체
WO2010052448A2 (en) * 2008-11-05 2010-05-14 Ucb Pharma S.A. Fused pyrazine derivatives as kinase inhibitors
CN102264721B (zh) 2008-11-10 2015-12-09 沃泰克斯药物股份有限公司 用作atr激酶抑制剂的化合物
RS56995B1 (sr) 2008-12-19 2018-05-31 Vertex Pharma Derivati pirazina korisni kao inhibitori atr kinaze
CA2750935A1 (en) 2009-01-30 2010-08-12 Millennium Pharmaceuticals, Inc. Heteroaryls and their use as pi3k inhibitors
US9090601B2 (en) * 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
TW201102065A (en) 2009-05-29 2011-01-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
FR2953519B1 (fr) * 2009-12-08 2012-02-10 Commissariat Energie Atomique Nouveaux composes chimiques aptes a complexer au moins un element metallique et complexe de coordination a base de ces composes
US20130096119A1 (en) 2010-03-31 2013-04-18 Daniel Bur Isoquinolin-3-Ylurea Derivatives
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
WO2011143423A2 (en) 2010-05-12 2011-11-17 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
US9334244B2 (en) 2010-05-12 2016-05-10 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
SG185524A1 (en) 2010-05-12 2012-12-28 Vertex Pharma Compounds useful as inhibitors of atr kinase
US8969356B2 (en) 2010-05-12 2015-03-03 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
WO2011143419A1 (en) 2010-05-12 2011-11-17 Vertex Pharmaceuticals Incorporated Pyrazines useful as inhibitors of atr kinase
CN102947272A (zh) * 2010-05-12 2013-02-27 沃泰克斯药物股份有限公司 用作atr激酶抑制剂的2-氨基吡啶衍生物
MX2013000103A (es) 2010-06-23 2013-06-13 Vertex Pharma Derivados de pirrolo-pirazina utiles como inhibidores de cinasa art.
WO2012021696A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2012021611A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2012021615A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
EP3590925B1 (en) 2010-09-17 2022-03-30 Purdue Pharma L.P. Pyridine compounds and the uses thereof
CN103237450A (zh) 2010-10-13 2013-08-07 米伦纽姆医药公司 杂芳基化合物和其用途
AR088729A1 (es) 2011-03-29 2014-07-02 Actelion Pharmaceuticals Ltd Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica
EP2694498B1 (en) 2011-04-05 2016-03-30 Vertex Pharmaceuticals Incorporated Aminopyrazine compounds useful as inhibitors of tra kinase
WO2012178124A1 (en) 2011-06-22 2012-12-27 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
WO2012178123A1 (en) 2011-06-22 2012-12-27 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
EP2723746A1 (en) 2011-06-22 2014-04-30 Vertex Pharmaceuticals Inc. Compounds useful as inhibitors of atr kinase
MX2014001860A (es) * 2011-09-12 2014-05-30 Hoffmann La Roche Hidrazidas del acido 3-piridin carboxilico como agentes elevadores del colesterol de lipoproteina de alta densidad (hdl).
WO2013049719A1 (en) 2011-09-30 2013-04-04 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
US8853217B2 (en) 2011-09-30 2014-10-07 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
CN108464983A (zh) 2011-09-30 2018-08-31 沃泰克斯药物股份有限公司 用atr抑制剂治疗胰腺癌和非小细胞肺癌
PT2940017T (pt) 2011-09-30 2019-10-31 Vertex Pharma Processos para a produção de compostos úteis como inibidores de atr quinase
WO2013049722A1 (en) 2011-09-30 2013-04-04 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
PE20142282A1 (es) * 2011-11-04 2015-01-08 Hoffmann La Roche Nuevos derivados de aril-quinolina
WO2013071088A1 (en) 2011-11-09 2013-05-16 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
US8846918B2 (en) 2011-11-09 2014-09-30 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
US8841337B2 (en) 2011-11-09 2014-09-23 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
US8841450B2 (en) 2011-11-09 2014-09-23 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
EP2776419B1 (en) 2011-11-09 2016-05-11 Vertex Pharmaceuticals Incorporated Pyrazine compounds useful as inhibitors of atr kinase
CN104125947A (zh) * 2011-12-21 2014-10-29 生物区欧洲有限公司 杂环脲化合物
NZ700580A (en) 2012-04-05 2016-07-29 Vertex Pharma Compounds useful as inhibitors of atr kinase and combination therapies thereof
US9546155B2 (en) 2012-06-15 2017-01-17 Mitsubishi Tanabe Pharma Corporation Aromatic heterocyclic compound
DK2904406T3 (en) 2012-10-04 2018-06-18 Vertex Pharma METHOD OF DETERMINING THE ATR INHIBITION, INCREASED DNA DAMAGE
WO2014062604A1 (en) 2012-10-16 2014-04-24 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
US9340546B2 (en) 2012-12-07 2016-05-17 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
US9242969B2 (en) 2013-03-14 2016-01-26 Novartis Ag Biaryl amide compounds as kinase inhibitors
WO2014143240A1 (en) 2013-03-15 2014-09-18 Vertex Pharmaceuticals Incorporated Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
ES2682040T3 (es) 2013-09-06 2018-09-18 Aurigene Discovery Technologies Limited Derivados de 1,3,4-oxadiazol y 1,3,4-tiadiazol como inmunomoduladores
HUE046727T2 (hu) 2013-12-06 2020-03-30 Vertex Pharma Az ATR-kináz inhibitoraként használható vegyület, 2-amino-6-fluoro-N-[5-fluoro-piridin-3-IL]-pirazolo-[1,5-A]-pirimidin-3-karboxamid, ennek elõállítása, különbözõ szilárd formái és ezek radioaktív nyomjelzett származékai
AU2015271030B2 (en) 2014-06-05 2019-05-16 Vertex Pharmaceuticals Incorporated Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]- pyrazolo [1,5-a] pyrimidin-3-carboxamide compound useful as ATR kinase inhibitor, the preparation of said compound and different solid forms thereof
PL3157566T3 (pl) 2014-06-17 2019-10-31 Vertex Pharma Metoda leczenia nowotworu przy użyciu kombinacji inhibitorów chk1 i atr
UY36294A (es) 2014-09-12 2016-04-29 Novartis Ag Compuestos y composiciones como inhibidores de quinasa
JP2018507884A (ja) * 2015-03-10 2018-03-22 オーリジーン ディスカバリー テクノロジーズ リミテッドＡｕｒｉｇｅｎｅ Ｄｉｓｃｏｖｅｒｙ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｉｍｉｔｅｄ 免疫調節剤としての３−置換１，３，４−オキサジアゾールおよびチアジアゾール化合物
JP7187308B2 (ja) 2015-09-30 2022-12-12 バーテックス ファーマシューティカルズ インコーポレイテッド Ｄｎａ損傷剤とａｔｒ阻害剤との組み合わせを使用する、がんを処置するための方法
CN106866571B (zh) * 2017-01-20 2018-06-29 中国药科大学 杂环脲类化合物及其药物组合物和应用
KR20190133667A (ko) 2017-03-24 2019-12-03 다이쇼 세이야꾸 가부시끼가이샤 2(1h)-퀴놀리논 유도체
CN111116559A (zh) * 2018-11-01 2020-05-08 复旦大学 吡啶脲类化合物及其制备方法和制药用途
WO2022147210A1 (en) * 2020-12-31 2022-07-07 Evrys Bio, Llc Anti-tumor compositions and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0014022D0 (en) * 2000-06-08 2000-08-02 Novartis Ag Organic compounds
AR042956A1 (es) * 2003-01-31 2005-07-13 Vertex Pharma Inhibidores de girasa y usos de los mismos
US7569591B2 (en) * 2003-01-31 2009-08-04 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
CL2007003470A1 (es) * 2006-12-04 2008-08-22 Astrazeneca Ab Compuestos derivados de urea; composicion farmaceutica que comprende a dichos compuestos; y su uso como antibacterianos.

Also Published As

Publication number Publication date
CL2009000426A1 (es) 2011-02-11
TW200940537A (en) 2009-10-01
PE20091573A1 (es) 2009-11-12
MX2010009163A (es) 2010-09-14
BRPI0907562A2 (pt) 2017-05-23
CA2716365A1 (en) 2009-09-03
DOP2010000259A (es) 2010-09-15
ZA201005997B (en) 2013-01-30
KR20100117681A (ko) 2010-11-03
AU2009219883A1 (en) 2009-09-03
US20120101100A1 (en) 2012-04-26
CR11641A (es) 2010-10-05
SA109300138B1 (ar) 2012-11-03
EP2262801A1 (en) 2010-12-22
CN102015699A (zh) 2011-04-13
AR070493A1 (es) 2010-04-07
IL207731A0 (en) 2010-12-30
CO6290656A2 (es) 2011-06-20
WO2009106885A1 (en) 2009-09-03
UY31673A1 (es) 2009-09-30
JP2011513216A (ja) 2011-04-28
ECSP10010419A (es) 2010-09-30

Similar Documents

Publication Publication Date Title
EA201001368A1 (ru) Гетероциклические производные мочевины и способы их применения-211
CY1124117T1 (el) Ετεροκυκλικες αλκυνυλοβενζολικες ενωσεις και ιατρικες συνθεσεις και χρησεις αυτων
EA201001858A1 (ru) Гетероциклические производные мочевины для лечения бактериальных инфекций
EA201001859A1 (ru) Гетероциклические производные мочевины и способы их применеия
UA96964C2 (ru) Соединения полициклической мочевины с антибактериальными свойствами
MX2007010072A (es) Derivados de piperidina antibacterianos.
EA201100613A1 (ru) Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций
EA201100971A1 (ru) Производные пиримидининдола для лечения злокачественного новообразования
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
MX2009011997A (es) Derivados de pirrolopirimidin-7-ona y su uso como farmaceuticos.
EA201390626A1 (ru) Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций
ATE514699T1 (de) Substituierte pyrrolopyrazolderivate als kinaseinhibitoren
CY1111442T1 (el) Ενωσεις πιπεριδινης και χρησεις αυτων
EA200870545A1 (ru) Новые гетероциклические соединения
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
EA201170722A1 (ru) Лактамы в качестве ингибиторов бета-секретазы
UY32856A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
UY32674A (es) Derivados heterociclicos de la urea y sus metodos de empleo
UY32694A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
EA201071352A1 (ru) Трициклические азотсодержащие соединения и их применение в качестве бактерицидных средств
UY32316A (es) Derivados de piperidina utiles en el tratamiento de infecciones bacterianas
EA201290229A1 (ru) Производные спиролактама и их применение
EA201100754A1 (ru) [4-(1-аминоэтил)циклогексил]метиламины в качестве антибактериальных средств
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
BR112012018658A2 (pt) sais farmaceuticamente aceitáveis de derivados heterocíclicos nitrogenosos - pirrolo, processo de preração e seu uso médico